scispace - formally typeset
Search or ask a question
Institution

Bethesda Hospital

HealthcareAmbur, Tamil Nadu, India
About: Bethesda Hospital is a healthcare organization based out in Ambur, Tamil Nadu, India. It is known for research contribution in the topics: Population & Helicobacter pylori. The organization has 386 authors who have published 472 publications receiving 15193 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: In this article, the authors evaluated the effectiveness and safety of switching the basal insulin (BI) in a BI-supported oral therapy (BOT) to insulin glargine 300 U/ml (Gla-300) in adults with inadequately controlled type 2 diabetes (T2D).
Abstract: AIMS This study evaluated the effectiveness and safety of switching the basal insulin (BI) in a BI-supported oral therapy (BOT) to insulin glargine 300 U/ml (Gla-300) in adults with inadequately controlled type 2 diabetes (T2D). MATERIALS AND METHODS This was a non-interventional, multicentre, prospective 12-month study, conducted in Germany, Austria and Switzerland. The study documented people with T2D with glycated haemoglobin (HbA1c) between 7.5% and 10.0%, currently treated by a non-Gla-300 BOT regimen, after the physician had decided to switch the BI to Gla-300. Primary endpoint was the proportion of patients achieving the fasting plasma glucose (FPG; ≤110 mg/dl) target. RESULTS In total, 1194 participants comprised the full analysis set, of which 793 completed documentation of 12 months Gla-300 treatment (FAS-M12). The main previous BI was insulin glargine 100 U/ml (Gla-100; 47.2%). Twelve months after switching to Gla-300, 27.0% of FAS-M12 participants achieved the FPG target and 44.8% their individualized HbA1c target. The greatest FPG target achievements were seen in previous Gla-100 (29.3%), and greatest HbA1c target achievements in previous insulin detemir users (57.7%). The mean FPG decreased by -36.3 ± 51.2 mg/dl to 135.5 ± 36.9 mg/dl and mean HbA1c by -0.79 ± 1.01% to 7.45 ± 0.94%. Symptomatic and nocturnal hypoglycaemia incidence significantly decreased over 12 months of Gla-300 treatment. Body weight remained unchanged. CONCLUSIONS Switching the BI to Gla-300 in a BOT regimen improved metabolic control and treatment satisfaction in a substantial proportion of patients with T2D and inadequate target achievement within 12 months in clinical practice with a decreased risk of symptomatic and nocturnal hypoglycaemia and without weight gain.

2 citations

Journal ArticleDOI
TL;DR: In this paper, Choi et al. reported that 4 out of 4명의 실어증을 동반한 말실행즉, 훈련, 치료 효과를 검 종결 2.
Abstract: 배경 및 목적: 실어증을 동반한 말실행증 증상을 보이는 성인들을 대상으로 반복연습과 말속도 통제 훈련을 실시하여 조음 능력의 정확성 향상에 관한 치료 효과를 검증하고자 한다. 방법: 4명의 실어증을 동반한 말실행증 성인을 대상으로 치료 전 검사, 낱말 반복연습, 구문 말속도 통제 훈련, 치료 후 검사, 치료 종결 2주 후에 훈련과제와 비훈련과제로 유지...

2 citations

Journal ArticleDOI
TL;DR: Prenatal SLE exposure was not associated with a statistically significant increase in the risk of cryptorchidism in male offspring, and the first-time report on the possible relationships between exposure to early and late pregnancy SLEs and risk of cryptography in a birth cohort is reported.
Abstract: Cryptorchidism, registered at birth or later, is the most common birth defect in males in western countries, estimated to affect around 2-3% of newborn boys, declining to around 2% at 3 months. We have previously described a potential association between stressful life events (SLEs) in pregnancy and reduced semen quality and testosterone levels in adult offspring. Both outcomes are believed to share a common etiology with cryptorchidism thus increased risk of cryptorchidism in boys exposed to prenatal SLEs may be plausible. The risk of cryptorchidism associated with prenatal SLE amongst 1,273 male Generation 2 offspring was estimated using the Western Australian Pregnancy (Raine) Study. SLEs are discrete experiences that disrupt an individual's usual activities causing a life change and readjustment, such as death of a relative or friend, divorce, illness or job loss. Mothers prospectively reported SLEs, during pregnancy at gestational weeks (GW) 18 and 34 using a standardized 10-point questionnaire. A boy was diagnosed as cryptorchid if one or both testes was non-palpable in the scrotum and not able to be manipulated into the scrotum. Twenty-four (2%) cryptorchid boys were identified. Mean (standard deviation) of SLE exposures in GW34 was 1.1 (1.2) for non-cryptorchid boys and slightly higher 1.5 (1.8) for cryptorchid boys, similar differences were observed in GW18. Adjusted odds ratio [OR] and 95% confidence intervals (CI) for risk of cryptorchidism in early (18-weeks) and late gestation (34-weeks) according to prenatal SLE exposures were: 1.06 (95% CI: 0.77-1.45) and 1.18 (95% CI: 0.84-1.67), respectively. This is the first-time report on the possible relationships between exposure to early and late pregnancy SLEs and risk of cryptorchidism in a birth cohort. Prenatal SLE exposure was not associated with a statistically significant increase in the risk of cryptorchidism in male offspring. A small case population limits the statistical power of the study and future larger studies are required to evaluate this potential association.

2 citations

Journal ArticleDOI
27 May 2020-Cureus
TL;DR: An 81-year-old woman presented with multiple episodes of loose bowel movements and CT scan of the abdomen and pelvis revealed pneumatosis cystoides intestinalis and asymptomatic emphysematous cystitis.
Abstract: An 81-year-old woman presented with multiple episodes of loose bowel movements. CT scan of the abdomen and pelvis revealed pneumatosis cystoides intestinalis and asymptomatic emphysematous cystitis. The patient had an extensive workup with no obvious identified pathology to explain diffuse pneumatosis of the small bowel and bladder. Her symptoms improved with symptomatic management, empirical antibiotics, and no surgical intervention.

2 citations


Authors

Showing all 387 results

NameH-indexPapersCitations
Jennie Ponsford7339318379
Peter J. Stern532358622
Roger Hart461547065
Glynda J. Kinsella401205752
Jacinta Douglas391804737
Gabriela Möslein361126057
Pamela Claire Snow361424496
Michael Denkinger341473214
Thomas Daikeler301413309
John Olver251033189
J. C. Thijs24462194
Daniel Navot24562705
Bernd Sanner231022652
Ulrike Nitz22984068
Dries Testelmans22922100
Network Information
Related Institutions (5)
NewYork–Presbyterian Hospital
25.3K papers, 1M citations

82% related

Cleveland Clinic
79.3K papers, 3.4M citations

82% related

VU University Medical Center
22.9K papers, 1.1M citations

81% related

Kaiser Permanente
24.3K papers, 1.2M citations

81% related

Beth Israel Deaconess Medical Center
52.5K papers, 2.9M citations

81% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20223
202148
202039
201927
201819
201723